| GILD Snapshot | |
|---|---|
| Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi. | |
| VALUATION DATA | |
| Market Capitalization | $83,646,751,000 | Price to Sales | 18.00 |
| Earnings per Share | $4.5000 |
| PE Ratio | 14.91 |
| PRICE DATA | |
| Most Recent Close | $67.0800 |
| 52 Week High | $3.13 |
| 52 Week Low | $3.717 |
| 50-Day Moving Average | $3.784 |
| 200-Day Moving Average | $9.78 |
| All data are from Alpha Vantage as of today. For more infomation on GILD see Stock Dividend, Valuation, Price and Financial Data for Investors | |
Custom Search